Embr Labs, a US-based thermal wellness technology developer, has secured six new foundational patents across the US, Japan, and the European Union (EU) for artificial intelligence (AI)-driven digital therapeutics.
The patents cover advanced systems using sensors and AI to deliver targeted warming or cooling stimuli, improving health and well-being.
According to Embr Labs, these patent protections strengthen its position in closed-loop digital thermal therapeutics.
It also paves the way for an advanced closed-loop solution for conditions related to sympathetic overactivation like menopausal and treatment-induced hot flashes, and stress.
Embr Labs’ patents showcase the future of AI-driven wearable thermal technology, offering non-pharmacological interventions as safe alternatives for managing hot flashes, stress, and anxiety, reducing the need for medications.
The technology provides personalised solutions, delivering thermal interventions tailored to individual physiological responses, which enhances both efficacy and outcomes.
Additionally, the devices are designed for continuous improvement, learning from user feedback and physiological data to optimise performance over time.
Embr Labs co-founder and chief technology officer Matt Smith said: “Our patented technologies are setting new standards for smart wearables by actively improving well-being, not just tracking it.
“By addressing the complex interplay between thermal stimuli and the autonomic nervous system, we’re offering the type of transformative, non-pharmacological solution that the world needs right now.”
The patents cover key inventions in the thermal waveforms sector. These patents specifically focus on thermal waveforms that are sensor-driven, with the Embr Wave delivering warming and cooling waves controlled by sensors that detect biomarkers like skin temperature and electrodermal activity, which reflect sympathetic nervous system responses.
It also covers closed-loop waveforms by generating warming and cooling waves in response to real-time physiological signals, providing immediate relief during hot flash episodes.
The system is a closed-loop, generating warming and cooling waves in response to real-time physiological signals, providing immediate relief during hot flash episodes.
The technology is adaptive, modifying thermal waves based on real-time sensor data, allowing for personalised management of hot flashes and anxiety symptoms.
Additionally, personalised algorithms are reinforced with user confirmation and physiological feedback, enhancing the effectiveness of symptom relief over time.
These patented technologies build upon the commercial and clinical success of the Embr Wave, Embr Labs’ flagship wearable device. It provides thermal comfort and relief from hot flashes.
In May last year, the health technology company raised $35m through intellectual property (IP)-based debt financing to fund its market expansion.
